Linked Life Data

10226564

Source:http://linkedlifedata.com/resource/pubmed/id/10226564

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1A
pubmed:dateCreated
1999-5-20
pubmed:abstractText
C-CAM1 functions as a tumor suppressor in prostate cancer. Thus C-CAM1 recombinant adenovirus therapy may be a promising treatment for prostate cancer. Understanding the time course of C-CAM1's antitumor activity is essential for designing an optimal schedule for C-CAM1 gene therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
337-40
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model.
pubmed:affiliation
Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. Slin@notes.mdacc.tmc.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't